Kiora Pharmaceuticals Inc. Common Stock (KPRX)

About KPRX

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

13

Website

www.kiorapharma.com

Fundamentals

1-day range

$2.48$2.59

Market cap

$11.48M

P/E (trailing)

—

P/E (forward)

-1.14

EPS (trailing)

$-2.41

Dividend yield

—

Beta

—

Avg. volume

24.3K

Dividend pay date

August 30, 2019

Forecasts

1 analyst ratings

Kiora Pharmaceuticals Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• KPRX

  Kiora Pharmaceuticals Inc. Common Stock

  $2.62

  ▼ 1.50%
  Market cap $11.48MP/E —
  $1.77$2.99
• PHIO

  Phio Pharmaceuticals Corp. Common Stock

  $1.13

  ▲ 0.45%
  Market cap $11.97MP/E —
  $0.8127$4.19
• AKTX

  Akari Therapeutics plc ADS

  $11.03

  ▲ 22.42%
  Market cap $12.88MP/E Infinity
  $3.02$49.6
• COCP

  Cocrystal Pharma Inc. Common Stock

  $1.11

  ▼ 2.63%
  Market cap $12.96MP/E —
  $0.76$2.67
• GDTC

  CytoMed Therapeutics Limited Ordinary Shares

  $0.92

  ▼ 4.17%
  Market cap $9.50MP/E —
  $0.6801$3.68
• AEON

  AEON Biopharma Inc. Class A Common Stock

  $0.3095

  ▲ 5.27%
  Market cap $14.41MP/E —
  $0.1772$1.45
• CNSP

  CNS Pharmaceuticals Inc. Common Stock

  $5.52

  ▲ 0.11%
  Market cap $8.46MP/E —
  $1.9$10.59

P/E shows — for peers not currently carrying a live signal of their own.

• Melissa Tosca · July 1, 2026 · Tax Withholding

  911 @ $2.66
• Brian M. Strem · July 1, 2026 · Tax Withholding

  1.9K @ $2.66
• Parsons Erin · June 10, 2026 · Grant

  25.0K
• Carmine N. Stengone · June 10, 2026 · Grant

  25.0K
• Aron Shapiro · June 10, 2026 · Grant

  25.0K
• Hollander David · June 10, 2026 · Grant

  25.0K
• Lisa Walters-Hoffert · June 10, 2026 · Grant

  25.0K
• Praveen Tyle · June 10, 2026 · Grant

  40.0K
• Melissa Tosca · April 1, 2026 · Tax Withholding

  929 @ $1.95
• Eric Joseph Daniels · April 1, 2026 · Tax Withholding

  929 @ $1.95
• Brian M. Strem · April 1, 2026 · Tax Withholding

  1.9K @ $1.95
• Eric Joseph Daniels · March 6, 2026 · Grant

  13.1K
• Eric Joseph Daniels · March 6, 2026 · Grant

  6.5K
• Brian M. Strem · March 6, 2026 · Grant

  33.5K
• Brian M. Strem · March 6, 2026 · Grant

  16.7K

Institutional Ownership

March 31, 2026

Total shares held

326.0K

Total value held

$629.1K

Institutional holders

15